Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.

CEO

Mr. Francesco Paolini

Employees

Country

Canada

ISIN

CA00258G1037

Listings

0 Comments

Share your thoughts

FAQ

What is Abattis Bioceuticals stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Abattis Bioceuticals stocks are traded under the ticker 115.MU.

What is Abattis Bioceuticals revenue for the last year?▼

Abattis Bioceuticals revenue for the last year amounts to 244,047.63 EUR.

What is Abattis Bioceuticals net income for the last year?▼

115.MU net income for the last year is -2.02M EUR.

How many employees does Abattis Bioceuticals have?▼

As of July 16, 2026, the company has 48 employees.

In which sector is Abattis Bioceuticals located?▼

Abattis Bioceuticals operates in the Health & Wellness sector.

When did Abattis Bioceuticals complete a stock split?▼

Abattis Bioceuticals has not had any recent stock splits.

Where is Abattis Bioceuticals headquartered?▼

Abattis Bioceuticals is headquartered in Vancouver, Canada.